Recombinant Human Erythropoietin to Correct Uremic Bleeding

Livio, 1985, Coagulation abnormalities in uremia, Semin Nephrol, 5, 82 Andrassy, 1985, Uremia as a cause of bleeding, Am J Nephrol, 5, 313, 10.1159/000166955 Remuzzi, 1988, Bleeding in renal failure, Lancet, 1, 1205, 10.1016/S0140-6736(88)92019-3 Steiner, 1979, Bleeding in uremia: A useful test to assess clinical bleeding, Am J Hematol, 7, 107, 10.1002/ajh.2830070203 Livio, 1982, Uraemic bleeding: Role of anaemia and beneficial effect of red cell transfusions, Lancet, 2, 1013, 10.1016/S0140-6736(82)90050-2 Fernandez, 1985, Low haematocrit and prolonged bleeding time in uraemic patients: Effect of red cell transfusions, Br J Haematol, 59, 139, 10.1111/j.1365-2141.1985.tb02974.x Winearls, 1986, Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis, Lancet, 2, 1175, 10.1016/S0140-6736(86)92192-6 Eschbach, 1987, Correction of the anemia of end-stage renal disease with recombinant human erythropoietin: results of a phase I and II clinical trial, N Engl J Med, 316, 73, 10.1056/NEJM198701083160203 Raine, 1988, Hypertension, blood viscosity, and cardiovascular morbidity in renal failure: Implications of erythropoietin therapy, Lancet, 1, 97, 10.1016/S0140-6736(88)90293-0 Schaefer, 1989, Treatment of renal anemia with recombinant human erythropoietin, Am J Nephrol, 9, 353, 10.1159/000167996 1989, Statement on the clinical use of recombinant erythropoietin in anemia of end-stage renal disease, Am J Kidney Dis, 14, 163, 10.1016/S0272-6386(89)80066-6 Moia, 1987, Improvement in the haemostatic defect of uraemia after treatment with recombinant human erythropoietin, Lancet, 2, 1127 Winearls, 1989, Treatment of anaemia in haemodialysis patients with recombinant erythropoietin, Nephron, 51, 26, 10.1159/000185567 Kumar, 1978, Clinical trial of a new bleeding-time device, Am J Clin Pathol, 70, 642, 10.1093/ajcp/70.4.642 Remuzzi, 1983, Reduced platelet thromboxane formation in uremia. Evidence for a functional cyclooxygenase defect, J Clin Invest, 71, 762, 10.1172/JCI110824 Linton, 1975 Turitto, 1980, Red blood cells: Their dual role on thrombus formation, Science, 207, 541, 10.1126/science.7352265 Begg, 1966, Components in blood viscosity. The relative contribution of haematocrit fibrinogen and other proteins, Clin Sci, 31, 87 Tomura, 1990, Enhanced platelet function and coagulability during treatment with recombinant erythropoietin (rEPO) in patients undergoing hemodialysis, Kidney Int, 37, 321 Turi, 1989, The effect of bicarbonate and acetate hemodialysis on platelet cAMP and aggregation Gordge, 1990, Recombinant human erythropoietin shortens the uraemic bleeding time without causing intravascular haemostatic activation, Thromb Res, 57, 171, 10.1016/0049-3848(90)90317-6 Van Geet, 1989, Haemostatic effects of recombinant human erythropoietin in chronic haemodialysis patients, Thromb Haemost, 61, 117, 10.1055/s-0038-1646538